Abstract
Current management of gastroesophageal reflux disease in the obese population - a review of the literature
Highlights
The obesity pandemic has become a significant global health problem
RYGB: roux-en-Y gastric bypass; gastro-esophageal reflux disease (GERD): gastroesophageal reflux disease; LSG: laparoscopic sleeve gastrectomy; ERAS: enhanced recovery after surgery; LINX: magnetic sphincter augmentation reflux management system frequently reported complication among surgeons surveyed at the Fourth International Consensus Summit on Sleeve Gastrectomy[52]
Obesity and GERD are both conditions with a significant impact on health-related quality of life and global health resource utilization
Summary
The obesity pandemic has become a significant global health problem. Since 1975, the world prevalence of obesity has nearly tripled, and at least 650 million adults currently have a BMI greater than 30 kg/m2. The United States is among the countries with the highest rates: more than 30% of adults are currently obese, with rates up to 40% in some regions of the country[1,2]. Multiple comorbidities have been associated with obesity, and gastro-esophageal reflux disease (GERD) is one of the most common. The incidence of GERD in the United States general population oscillates around 15%, whereas among obese patients it ranges from 22% to 70%[3,4]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
